z-logo
open-access-imgOpen Access
Drug discovery of PD-L1 inhibitor Atezolizumab
Author(s) -
Xinying Guo,
Xinyi Sheng
Publication year - 2022
Publication title -
highlights in science engineering and technology
Language(s) - English
Resource type - Journals
ISSN - 2791-0210
DOI - 10.54097/hset.v8i.1253
Subject(s) - atezolizumab , medicine , drug , immunotherapy , intensive care medicine , disease , refractory (planetary science) , oncology , pembrolizumab , cancer , pharmacology , physics , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom